Chen, Hong
Wen, Yan
Zeng, Yun
Lin, Lie
Sun, Bihong
Zhu, Hongqian
He, Huiqing
Wang, Xiaotao
Zou, Waiyi
Zheng, Caifeng
Zheng, Liling
Huang, Jinxiong
Pang, Liping
Huang, Jixian
Zhang, Yuming
Lin, Haiqing
Liu, Zelin
Zhu, Wanshou
Wang, Qiang
Zhou, Xuan
Liu, Xiaoli
Qu, Hong
Liu, Zhenfang
Du, Xin
Clinical trials referenced in this document:
Documents that mention this clinical trial
Patient Versus Physician Perspective in the Management of Chronic Myeloid Leukemia During Treatment with Tyrosine Kinase Inhibitors
https://doi.org/10.1007/s40487-023-00255-2
Funding for this research was provided by:
Natural Science Foundation of Guangdong Province (2020A1515010409)
Guangzhou Municipal Science and Technology Bureau (201904010488)
National Natural Science Foundation of China (82160039, 81700162)
the Open project of Yunnan Blood Disease Clinical Medical Center (2020LCZXKF-XY05)
the Key Basic Research Project of Guangzhou City-Basic and The Applied Basic Research Program of Science (202201011781)
Article History
Received: 1 September 2023
Accepted: 21 November 2023
First Online: 16 December 2023
Declarations
:
: Hong Chen, Yan Wen, Yun Zeng, Lie Lin, Bihong Sun, Hongqian Zhu, Huiqing He, Xiaotao Wang, Waiyi Zou, Caifeng Zheng, Liling Zheng, Jinxiong Huang, Liping Pang, Jixian Huang, Yuming Zhang, Haiqing Lin, Zelin Liu, Wanshou Zhu, Qiang Wang, Xuan Zhou, Xiaoli Liu, Hong Qu, Zhenfang Liu, Xin Du and Na Xu have nothing to disclose.
: The study was reviewed by the Medical Ethics Committee of Southern Medical University Nanfang Hospital, who confirmed that the research qualified as exempt from medical ethical review under Article 1, “Conducting research using legally obtained public data or data generated through observation without interfering with public behavior,” as outlined in the exemption from medical ethics review instructions. Therefore, the application for exemption from medical ethics review for this study was approved. All enrolled patients provided written informed consent before beginning the survey, and the trial was conducted in line with the principles of the Declaration of Helsinki. This study was registered at ClinicalTrials.gov (NCT05092048).